Workflow
百花医药(600721) - 2014 Q3 - 季度财报
BHCBHC(SH:600721)2014-10-27 16:00

Financial Performance - Operating revenue for the first nine months was CNY 714,620,034.31, a decrease of 16.61% year-on-year[8] - Net profit attributable to shareholders was a loss of CNY 141,722,733.74, representing an increase in loss of 88.85% compared to the previous year[8] - Basic earnings per share were -0.5214 CNY, a decrease of 522.20% compared to the previous year[8] - Total operating revenue for the third quarter was ¥279,155,527.61, a decrease of 7.5% compared to ¥300,675,618.16 in the same period last year[31] - Total operating costs increased to ¥414,485,372.68, up 29.8% from ¥319,174,440.72 year-over-year[31] - Net loss for the third quarter was ¥131,694,882.88, compared to a loss of ¥18,653,289.62 in the same quarter last year[32] - Operating profit for the third quarter was a loss of ¥135,379,967.27, compared to a loss of ¥18,505,734.16 in the previous year[32] - The company reported a significant increase in asset impairment losses, which rose to ¥24,280,542.43 from ¥4,828,448.49 year-over-year[31] - The company reported a net loss of CNY 80,351,408.03 in retained earnings, compared to a profit of CNY 59,818,409.30 at the beginning of the year[26] Assets and Liabilities - Total assets decreased by 3.41% to CNY 4,385,008,227.38 compared to the end of the previous year[7] - Total liabilities increased from CNY 3,166,326,222.79 to CNY 3,237,265,948.96, an increase of approximately 2.2%[26] - The ending balance of accounts receivable is 139 million yuan, an increase of 39.52% compared to the previous year, mainly due to an increase in receivables from sales[12] - The ending balance of notes receivable is 29.95 million yuan, a decrease of 74.85% compared to the previous year, primarily due to the maturity of bank acceptance bills[12] - The ending balance of deferred tax assets is 19.08 million yuan, an increase of 37.68% compared to the previous year, mainly due to the provision for impairment made by subsidiaries[13] - The ending balance of long-term payables is 293 million yuan, an increase of 109.14% compared to the previous year, mainly due to increased equipment financing lease payments from subsidiaries[13] - The ending balance of special payables is 28.29 million yuan, an increase of 62.56% compared to the previous year, mainly due to funds received for urban renovation projects[14] - The ending balance of accounts payable is 102.10 million yuan, an increase of 256.99% compared to the previous year, mainly due to increased notes from subsidiaries[13] Cash Flow - Cash flow from operating activities decreased by 19.39% to CNY 97,105,640.31 for the first nine months[7] - Cash flow from investment activities is -29.13 million yuan, an increase of 62.08% compared to the previous year, mainly due to reduced cash payments for fixed assets and intangible assets[15] - Cash inflow from operating activities for the first nine months of 2014 was CNY 169,927,300.95, an increase from CNY 116,889,012.02 in the same period last year, representing an increase of approximately 45.2%[40] - Net cash flow from operating activities for Q3 2014 was CNY 97,105,640.31, compared to CNY 120,457,394.23 in the same period last year, reflecting a decrease of approximately 19.3%[37] - Cash inflow from financing activities in Q3 2014 was CNY 1,234,396,300.00, significantly higher than CNY 885,527,744.43 in the prior year, marking an increase of approximately 39.3%[38] - The net increase in cash and cash equivalents for Q3 2014 was CNY 88,256,906.45, down from CNY 148,887,105.23 in the same quarter last year, indicating a decrease of approximately 40.6%[39] Shareholder Information - The total number of shareholders at the end of the reporting period was 14,136[10] - The largest shareholder, the Sixth Division of the Xinjiang Production and Construction Corps, holds 48.78% of shares[10] - The company expects a cumulative net profit for the year to be a loss, influenced by the downturn in the "coal-coke-steel" and "coal-coke-chemical" industry chains[17]